NCT00391755View on ClinicalTrials.gov

A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches

PHASE4TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Migraine Headache
Interventions
DRUG

ramelteon

"1. ramelteon 8mg po qhs with sleep and headache diary~2. placebo 1 po qhs with sleep and headache diary"

Trial Locations (1)

22902

Patricia Shipley, MD, Charlottesville

Sponsors
All Listed Sponsors
collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

lead

Charlottesville Neuroscience

OTHER